Medications

Maker of Wegovy limits supply of obesity drug in US

Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.

Overweight & Obesity

Popularity of weight loss drugs soars, but weight stigma persists

Weight loss has always been a hot topic in the media, and now, with the rise in popularity of a class of drugs that induce weight loss, it's more controversial than ever. These drugs, including Ozempic, which is approved ...

page 8 from 18